Astringent
NDC 63561-0178, Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate, powder, for solution, from Granulation Technology, Inc..
- Product NDC
- 63561-0178
- Status
- Listed
- Labeler
- Granulation Technology, Inc.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- part347
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0178 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM ACETATE MONOHYDRATE952 mg/2299mg
- ALUMINUM SULFATE TETRADECAHYDRATE1347 mg/2299mg
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63561-0178-2 | 63561017802 | 12 PACKET in 1 CARTON (63561-0178-2) / 2299 mg in 1 PACKET (63561-0178-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63561-0178 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63561-0178 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63561-0178. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.